Novartis plots new Pluvicto filing timeline after waiting for overall survival results
Novartis said Thursday in a brief, five-sentence press release that it plans to file for an expanded label for its prostate …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
